Report Detail

Pharma & Healthcare Global Infertility Drugs Market Growth (Status and Outlook) 2019-2024

  • RnM3282688
  • |
  • 08 April, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
Market competition is not intense. Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
North America is the largest consumption place, with a consumption market share nearly 44% in 2017. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
Infertility Drugs is widely used for males and females. The most proportion of Infertility Drugs is used for females, and the revenue in 2017 is 89%.

According to this study, over the next five years the Infertility Drugs market will register a 5.2% CAGR in terms of revenue, the global market size will reach US$ 5310 million by 2024, from US$ 4120 million in 2019. In particular, this report presents the global revenue market share of key companies in Infertility Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Infertility Drugs market by product type, application, key companies and key regions.

This study considers the Infertility Drugs value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Gonadotropins
Anti-Estrogens
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Male
Female

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Infertility Drugs market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Infertility Drugs market by identifying its various subsegments.
Focuses on the key global Infertility Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Infertility Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Infertility Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Infertility Drugs Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Infertility Drugs Market Size 2014-2024
        • 2.1.2 Infertility Drugs Market Size CAGR by Region
      • 2.2 Infertility Drugs Segment by Type
        • 2.2.1 Gonadotropins
        • 2.2.2 Anti-Estrogens
      • 2.3 Infertility Drugs Market Size by Type
        • 2.3.1 Global Infertility Drugs Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Infertility Drugs Market Size Growth Rate by Type (2014-2019)
      • 2.4 Infertility Drugs Segment by Application
        • 2.4.1 Male
        • 2.4.2 Female
      • 2.5 Infertility Drugs Market Size by Application
        • 2.5.1 Global Infertility Drugs Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Infertility Drugs Market Size Growth Rate by Application (2014-2019)

      3 Global Infertility Drugs by Players

      • 3.1 Global Infertility Drugs Market Size Market Share by Players
        • 3.1.1 Global Infertility Drugs Market Size by Players (2017-2019)
        • 3.1.2 Global Infertility Drugs Market Size Market Share by Players (2017-2019)
      • 3.2 Global Infertility Drugs Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Infertility Drugs by Regions

      • 4.1 Infertility Drugs Market Size by Regions
      • 4.2 Americas Infertility Drugs Market Size Growth
      • 4.3 APAC Infertility Drugs Market Size Growth
      • 4.4 Europe Infertility Drugs Market Size Growth
      • 4.5 Middle East & Africa Infertility Drugs Market Size Growth

      5 Americas

      • 5.1 Americas Infertility Drugs Market Size by Countries
      • 5.2 Americas Infertility Drugs Market Size by Type
      • 5.3 Americas Infertility Drugs Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Infertility Drugs Market Size by Countries
      • 6.2 APAC Infertility Drugs Market Size by Type
      • 6.3 APAC Infertility Drugs Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Infertility Drugs by Countries
      • 7.2 Europe Infertility Drugs Market Size by Type
      • 7.3 Europe Infertility Drugs Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Infertility Drugs by Countries
      • 8.2 Middle East & Africa Infertility Drugs Market Size by Type
      • 8.3 Middle East & Africa Infertility Drugs Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Infertility Drugs Market Forecast

      • 10.1 Global Infertility Drugs Market Size Forecast (2019-2024)
      • 10.2 Global Infertility Drugs Forecast by Regions
        • 10.2.1 Global Infertility Drugs Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Infertility Drugs Forecast by Type
      • 10.8 Global Infertility Drugs Forecast by Application

      11 Key Players Analysis

      • 11.1 Merck
        • 11.1.1 Company Details
        • 11.1.2 Infertility Drugs Product Offered
        • 11.1.3 Merck Infertility Drugs Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Merck News
      • 11.2 Ferring
        • 11.2.1 Company Details
        • 11.2.2 Infertility Drugs Product Offered
        • 11.2.3 Ferring Infertility Drugs Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Ferring News
      • 11.3 MSD
        • 11.3.1 Company Details
        • 11.3.2 Infertility Drugs Product Offered
        • 11.3.3 MSD Infertility Drugs Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 MSD News
      • 11.4 LIVZON
        • 11.4.1 Company Details
        • 11.4.2 Infertility Drugs Product Offered
        • 11.4.3 LIVZON Infertility Drugs Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 LIVZON News
      • 11.5 Abbott
        • 11.5.1 Company Details
        • 11.5.2 Infertility Drugs Product Offered
        • 11.5.3 Abbott Infertility Drugs Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Abbott News
      • 11.6 Bayer Zydus Pharma
        • 11.6.1 Company Details
        • 11.6.2 Infertility Drugs Product Offered
        • 11.6.3 Bayer Zydus Pharma Infertility Drugs Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Bayer Zydus Pharma News

      ...

        12 Research Findings and Conclusion

        Summary:
        Get latest Market Research Reports on Infertility Drugs . Industry analysis & Market Report on Infertility Drugs is a syndicated market report, published as Global Infertility Drugs Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Infertility Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,660.00
        $5,490.00
        $7,320.00
        2,887.74
        4,331.61
        5,775.48
        3,367.20
        5,050.80
        6,734.40
        567,922.20
        851,883.30
        1,135,844.40
        305,610.00
        458,415.00
        611,220.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report